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of Calves with Bovine Immunodeficiency-Like Virus
Abstract
The early pathogenic effects of bovine immunodeficiency-like virus (BIV) were studied in calves
experimentally inoculated with BIV. All animals inoculated with BIV R29-infected cells seroconverted by 6
weeks postinoculation, and BIV was recoverable from each animal at 2 weeks postinoculation. However, levels
of BIV replication in vivo appeared to be low. In situ hybridization studies indicated that during peak periods
of viral replication in vivo, less than 0.03% of peripheral blood mononuclear cells were expressing detectable
levels of viral RNA. Moreover, the levels of viral RNA in these cells in vivo were less than 1/10 the levels
observed in persistently infected cells in vitro. BIV-inoculated calves had significantly higher numbers of
circulating lymphocytes, and follicular hyperplasia was observed in lymph nodes, hemal nodes, and spleen.
The histopathological changes observed in BIV-infected calves were similar to changes found early after
infection with the immunosuppressive lentiviruses, including human immunodeficiency virus type 1.
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The early pathogenic effects of bovine immunodeficiency-like virus (BIV) were studied in calves experimen· 
tally inoculated with BIV. All animals inoculated with BIV R29-infected ceUs seroconverted by 6 weeks 
postinoculation, and BIV was recoverable from each animal at 2 weeks postinoculation. However, levels of BIV 
replication in vivo appeared to be low. In situ hybridization studies indicated that during peak periods of viral 
replication in vivo, less than 0.03% of peripheral blood mononuclear cells were expressing detectable levels of 
viral RNA. Moreover, the levels of viral RNA in these cells in vivo were less than 1/10 the levels observed in 
persistently infected ceUs in vitro. BIV ·inoculated calves had significantly higher numbers of circulating 
lymphocytes, and foUicular hyperplasia was observed in lymph nodes, hemal nodes, and spleen. The 
histopathological changes observed in BIV -infected calves were similar to changes found early after infection 
with the immunosuppressive lentiviruses, including humBil immunodeficiency virus type 1. 
Lentiviruses are exogenous, nononcogenic retroviruses 
which induce chronic, persistent disease in infected individ-
uals. The lentivirus family includes the visna-maedi virus, 
caprine arthritis-encephalitis virus, equine infectious anemia 
virus, bovine immunodeficiency-like virus (BIV), and the 
human (HIV), simian (SlY), and feline (FlY) immunodefi-
ciency viruses. Clinical manifestations of lentivirus infec-
tions vary widely, both among the different members of the 
lentivirus family as well as among individuals inoculated 
with the same virus. In general, lentivirus disease has been 
described as primary and secondary (27). Primary disease is 
found in all lentivirus infections and is associated with 
increased viral replication in macrophage populations in 
affected tissues. The differences in clinical disease among 
the various members of the lentivirus family are due primar-
ily to the target organ affected and, in some cases, to the 
tempo of virus replication and induction of disease. Second-
ary disease is associated with viral replication in CD4+ 
lymphocytes and immune suppression (27). Thus far, sec-
ondary disease has been described only for primate and 
feline lentivirus infections. 
BIV is a member of the lentivirus family which has 
received only limited in vivo study (38, 39). In 1972, Van-
DerMaaten et al. reported the isolation of a virus from cattle 
with persistent lymphocytosis (38). At necropsy, affected 
cattle were found to exhibit lymphoid hyperplasia and mild 
lymphocytic perivascular cuffing in the brain. Experimental 
infection of colostrum-deprived calves resulted in mild tran-
sient leukocytosis and moderate lymphadenopathy. Electron 
microscopic examination demonstrated that the causative 
virus was morphologically similar to visna virus (11, 38). 
More recent studies have shown that the bovine visna-like 
virus is antigenically and genetically related to other mem-
* Corresponding author. 
t Present address: Laboratory of Molecular Pathobiology, De-
partment of Pharmacology and Pathobiology, The Royal Veterinary 
and Agricultural University of Copenhagen, Copenhagen, Denmark. 
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bers of the lentivirus subfamily of retroviruses, including 
HIV, and in 1987 the virus was named bovine immunodefi-
ciency-like virus (21). The structural similarities between 
BIV and HIV, as well as the occurrence of lymphadenopa-
thy in experimentally infected calves, suggests that BIV may 
provide a useful animal model for HIV pathogenesis. How-
ever, few studies of BIV pathogenesis in experimentally 
infected calves have been reported since the original descrip-
tion of VanDerMaaten et al. (38). Those iriitial studies of 
experimental BIV infection identified a transient leukocyto-
sis within the first 1 to 2 months following infection. In 
addition, BIV could be reisolated from experimentally in-
fected calves during the first 2 months postinfection; how-
ever, samples collected at 16 weeks postinoculation (p.i.) or 
later were consistently negative. These data suggested that 
an early acute phase, similar to that observed in infections 
with several other lentiviruses, including equine infectious 
anemia virus (22), HIV (18), SlY (25), and FlY (44), may be 
characteristic of BIV infections in vivo. Therefore, we 
undertook this study to examine the in vivo effects of BIV 
during early periods following experimental infection of 
calves. 
MATERIALS AND METHODS 
Virus and ceUs. All BIV inocula used in these studies were 
derived from the original R29 isolate of BIV, the only 
reported field isolate of BIV. Stocks of BIV R29 had been 
passaged more than 25 times in primary cultures of bovine 
embryonic spleen (BESP) and fetal bovine lung (FBL) cells 
prior to use in these studies. The molecularly cloned BIV 106 
isolate, derived from BIV R29 (12), was obtained as a 50-ml 
stock of cell-free virus from Matthew Gonda, NCI-Program 
Resources, Inc., Frederick, Md., and was used in these 
studies without further in vitro passage. The FBL-BIV R29 
inoculum was prepared by cocultivation of BIV R29-infected 
FBL cells with noninfected FBL cells as previously de-
scribed (42). This method of in vitro propagation of BIV was 
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previously shown to result in a significant increase in BIV 
antigen production (42). All of the BIV inocula were known 
to contain noncytopathic bovine viral diarrhea virus 
(BVDV), a common contaminant of commercial lots of fetal 
calf serum used in animal cell culture (10). 
Madin-Darby bovine kidney cells (MDBK; ATCC CCL-
22) were grown in Dulbecco modified Eagle's medium sup-
plemented with 10% fetal bovine serum, 1% newborn calf 
serum, and antibiotics. Primary BESP and FBL cultures 
were established and maintained as previously described 
(24, 42). MDBK and FBL cultures were repeatedly tested 
and shown to be free of BVDV. 
Animals and inoculations. Holstein calves, 2 to 4 months of 
age, were purchased from a local dairy and used for in vivo 
studies. All calves were serologically determined to be free 
of BVDV and bovine leukemia virus (BL V) prior to exper-
imental inoculation. In the first series of experiments, BIV 
R29 propagated in BESP cells was serially passed through 
five calves. The passage 1 (pl) calf was inoculated intrave-
nously (i.v.) with approximately 107 BIV-infected BESP 
cells in 40 ml of culture supernatant. Two weeks p.i., 100 ml 
of whole blood was collected from this calf and immediately 
inoculated i. v. into a second calf. Previous studies indicated 
that BIV was consistently reisolated from experimentally 
infected calves at 2 weeks p.i. (38). Subsequent passages of 
100 ml of whole blood into recipient calves were done at 2 to 
3 weeks p.i. In the second experiment, the molecularly 
cloned BIV 106 isolate was serially passaged through three 
calves. The pl calf was inoculated i. v. with 40 ml of cell-free 
supernatant containing BIV 106. As before, 100 ml of whole 
blood was passaged 2 weeks p.i. 
A third experiment was designed to address the effect of 
BVDV present in the BIV inocula. All calves in this exper-
iment were vaccinated with killed BVDV vaccine (EXCEL 
4; Bio-Ceutic, St. Joseph, Mo.) at 2 and 4 weeks preinoc-
ulation. Four colostrum-deprived Holstein calves, 4 to 6 
months of age, were inoculated with 1.8 x 104 syncytium-
forming units ofBIV R29 propagated in FBL cells (FBL-BIV 
R29). Three colostrum-deprived age-matched calves were 
inoculated with FBL cells as negative controls. To control 
for the effects of BVDV present in the BIV inocula, the 
noncytopathic Nebraska isolate of BVDV (32) was included 
in the FBL control inocula. 
Clinical and pathological signs of BIV infection. Blood 
samples were collected and rectal temperatures were re-
corded at least three times per week. Hematological analy-
ses included total and differential leukocyte counts. The 
normal range of lymphocyte and neutrophil counts was 
determined from a total of 123 samplings from age-matched 
calves. For the purposes of this study, the normal range for 
the lymphocyte and neutrophil counts was defined as the 
range that contained 95% of the values from these control 
animals. 
Animals in the BIV R29 serial passage experiments were 
euthanized at 5 to 6 weeks p.i. and examined for gross and 
histopathological lesions. Also included was a single control 
calf inoculated with 2.5 x 107 peripheral blood mononuclear 
cells (PBMC) from an allogenic calf free of BIV, BL V, and 
BVDV. At necropsy, representative specimens obtained 
from the lymphoid system, thoracic and abdominal viscera, 
central nervous system, and femoral bone marrow were 
fixed by immersion in 10% neutral buffered formalin. Fixed 
tissues were embedded in paraffin, sectioned at 5 ~m. and 
stained with hematoxylin and eosin (H&E). Lymph nodes 
were examined for structural alterations in follicular, para-
cortical, medullary cord, and sinus compartments (6, 30, 40). 
EARLY PATHOGENESIS OF BIV 1075 
Hemal nodes and other lymphoid tissues were examined for 
relative content of follicular and nonfollicular lymphoid 
elements (26, 28). 
Virus isolation. For virus isolation, whole blood was 
collected into acid citrate dextrose at 2 and 6 weeks p.i., and 
PBMC were isolated by centrifugation, collection of the 
buffy coat, and flash lysis of the erythrocytes in the buffy 
coat as previously described (33). This resulted in a popula-
tion of greater than 90% mononuclear cells. A total of 107 to 
108 PBMC were cocultivated with 5 x lOS BESP or FBL 
cells, and BIV replication was detected by syncytium for-
mation (38). In some cases, an indirect immunofluorescence 
assay was used to confirm the presence of BIV. For these 
assays, cells were fixed in 70% acetone-30% methanol and 
incubated for 30 min at room temperature with 0.5 ml of a 
predetermined dilution of BIV -specific antibody in Hanks 
balanced salt solution. The polyclonal BIV-specific anti-
body, obtained from a calf experimentally inoculated with 
BIV, was free of antibody to BVDV, BL V, and bovine 
spumavirus. Following incubation with antibody, cells were 
washed twice in Hanks balanced salt solution and incubated 
with a predetermined dilution of fluoresceinated anti-bovine 
immunoglobulin G antibody (Jackson ImmunoResearch 
Laboratories, West Grove, Pa.). Cells were incubated, 
washed as described above, and examined for BIV -specific 
immunofluorescence. All cultures were passaged at least 
three times before they were considered virus negative. 
Antibody detection. Serum samples collected from exper-
imentally inoculated calves at 5 to 6 weeks p.i. were tested 
for antibodies to BIV by Western immunoblot assays as 
previously described (41, 42). A focal immunofluorescence 
assay (14, 15, 35) was used for detection of BVDV-specific 
antibody. A total of 5 x lOS BVDV -free MDBK cells were 
seeded in 60-mm tissue culture dishes, and lQl MDBK cells 
chronically infected with noncytopathic BVDV were added 
the following day. After 4 days, cells were fixed as described 
above and incubated with serial twofold dilutioqs of sera 
collected from experimentally infected and control calves. 
Positive control sera included convalescent sera from a 
BVDV-infected calf. Following 30 min of incubation at room 
temperature, cells were washed, treated with secondary 
antibody, and examined for BVDV -specific immunofluores-
cence. 
In situ hybridization. All enzymes, isotopes, vectors, and 
other chemicals were from sources previously detailed (1-3, 
5, 9). The complete 587-nucleotide sequence of the BIV long 
terminal repeat (L TR) was amplified by using the polymer-
ase chain reaction (PCR) and cloned as follows. Oligonucle-
otide primers spanning nucleotides 1 to 20 of the 5' end of the 
U3 region and complementary to nucleotides 570 to 587 in 
the 3' end of the U5 region were designed on the basis ofthe 
published sequence of BIV (19). Each of these primers 
included eight additional5' nucleotides containing a Hindiii 
site. Two primers complementary to sequences in the central 
region were also synthesized. Total DNA was extracted 
from MDBK cells chronically infected with BIV R29, and 
100 ng of DNA was amplified for 25 cycles, using the LTR 
terminal primers and PCR conditions as previously de-
scribed (4, 13). The PCR-amplified products were partially 
purified by phenol-chloroform extraction, digested with 
Hindiii, and ligated into the Hindiii site of pUC19. Colonies 
were blotted onto nylon membranes and probed with the 
internal LTR oligonucleotides 5' end labelled with 32P as 
previously described (4, 13). Positive colonies were picked 
and replated twice. A single positive clone, designated 
4-N#l.6, was further characterized by restriction enzyme 
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1076 CARPENTER ET AL. 
mapping and dideoxy DNA nucleotide sequencing as we 
previously described (1, 8, 13). The nucleotide sequence of 
4-N#1.6 was more than 99% homologous to the sequences 
previously reported (19). 
For use in strand-specific in situ hybridization, the BIV 
LTR was subcloned in the Hindiii site of pGEM4Z 
(Promega Biotec, Madison, Wis.). Clones containing a single 
BIV LTR insert in the forward orientation with respect to 
the T7 promoter (clone 5-H#l1.2, producing a plus-sense 
RNA transcript) and in the reverse orientation (clone 
5-H#l1.3, producing a minus-sense transcript) were identi-
fied. For use as probes, DNA from plasmids 5-H#11.2 and 
5-H#11.3 was linearized to completion with Smai and 
transcribed in vitro under conditions previously detailed (3, 
9). The RNA was radiolabelled with [32P]UTP for filter blot 
hybridizations and with [35S]UTP for in situ hybridization. 
The size of the transcripts was verified by electrophoresis of 
a portion of the labelled RNAs into a formaldehyde-agarose 
gel and comparison with known standards. Approximately 
100 to 200 ng of RNA transcript of about 600 nucleotides in 
length and a specific activity of 3 x lOS cpm/JLg could be 
produced from 200 ng of plasmid DNA. The sense specificity 
of the probes was tested by hybridization to replicate North-
em (RNA) blots of total RNA isolated from BIV-infected 
MDBK cells (1, 3, 9). BIV RNA reacted with the minus-
sense probe but not with the plus-sense probe (data not 
shown). For a detailed discussion of strand-specific probes, 
the reader is referred to previous reports (1-3, 5, 7, 9, 37). 
The in situ hybridizations were performed on periodate-
lysine-paraformaldehyde-glutaraldehyde-fixed cells and tis-
sues as previously described (2, 3, 5, 7, 37) except that the 
BIV probes were used and the temperature of stringent wash 
was lowered to 50°C. The LTR sequences were chosen as 
probes in order to rule out any possible cross-hybridization 
to BLV, as the BIV and BLV LTRs are only 40% related at 
the nucleotide level (19, 34). RNA probes were chosen 
because they give excellent sensitivity and specificity due to 
the posthybridization RNase step. 
RESULTS 
Clinical and hematological changes following experimental 
inoculation of calves with BIV. We undertook a series of 
experiments to characterize the in vivo virulence of BIV R29 
during the first 6 weeks after infection and to determine 
whether viral virulence could be increased following rapid in 
vivo passage. Following inoculation, calves were examined 
at least three times per week for changes in temperature and 
hematological profiles. No hematological values outside the 
normal range were observed in the pl calf inoculated with 
BESP cell culture-derived R29 (Fig. 1). Multiple transient 
episodes of neutropenia were observed in the p2 through p4 
calves. In these cases, an initial period of neutropenia 
occurred at 5 to 15 days p.i., followed by a second cycle of 
neutropenia at approximately 4 weeks p.i. The lack of the 
initial period of neutropenia in the p5 calf may be due to the 
development of pneumonia in this calf at 3 days p.i. At that 
time, the calf was treated with antibiotic for 2 days, and it 
quickly recovered. All other animals remained clinically 
normal throughout the experimental period. Increased num-
bers of lymphocytes were observed in several BIV R29 
passage calves, notably the p2 and p5 calves. However, the 
lymphocyte values were all within the normal range. Isolated 
days offever occurred in the p2 and p3 calves, while a more 
extended febrile response, most likely associated with pneu-
monia, was observed in the p5 calf. 
J. VIROL. 
In a second series of experiments, we passaged the 
molecularly cloned BIV 106 isolate through three calves. 
BIV 106 is an R29-derived molecular clone of BIV previ-
ously shown to be infectious for bovine cells in vitro (12). 
Cell-free stocks of BIV 106 were inoculated directly into a 
Holstein calf and passaged three times in vivo as described 
above. Following inoculation, the BIV 106 pl calf experi-
enced a prolonged febrile response and severe neutropenia 
(Fig. 1). Clinical signs included anorexia, lethargy, ataxia, 
and diarrhea. The BIV 106 p2 calf experienced milder fever 
and neutropenia, while the p3 calf was intermediate in both 
parameters. No other clinical signs or hematological changes 
were observed in either the p2 or p3 calf. 
Fever and leukopenia are characteristic of acute infection 
with BVDV (23, 32, 36). BVDV is a common contaminant of 
cell culture material (10) and, in fact, is present in all stocks 
of BIV which we have examined (data not shown). There-
fore, additional experiments were undertaken to clarify the 
respective roles of BIV and BVDV in the inocula. Seven 
colostrum-deprived calves seronegative for BL V and BVDV 
were vaccinated with killed BVDV vaccine at 2 and 4 weeks 
prior to inoculation with BIV. Four calves were inoculated 
with 50 ml of FBL containing 1.8 x 104 syncytium-forming 
units of BIV R29. The remaining three calves received 50 ml 
ofBIV-free FBL cells. Noncytopathic BVDV was present in 
all inocula. Calves were monitored for changes in tempera-
ture and hematological profile as described above. 
FBL-BIV R29-infected calves had significantly higher 
numbers of circulating lymphocytes than did the FBL con-
trols during the first 6 weeks p.i. The mean lymphocyte 
count in the BIV -inoculated animals during the first 6 weeks 
p.i. (5,940 cells per JLl}, was significantly higher (P < 0.02) 
than the mean of the control group (4,093 cells per JLl}. In 
addition, two of the four BIV-inoculated calves had lympho-
cyte counts above the normal range (Fig. 2). This was in 
marked contrast to the control calves, for which lymphocyte 
counts were often observed to be below the normal range, 
indicative of the lymphopenic effects ofBVDV (33). BVDV-
associated neutropenia was observed in both groups of 
calves. The mean number of neutrophils in the FBL-BIV 
R29 calves was lower than in the FBL controls; however, 
the means were not significantly different. Both groups of 
calves experienced transient fever during the first 2 weeks 
p.i., and no differences were observed between the groups in 
the severity or duration offever (data not shown). Thus, the 
only hematological effect that could be directly attributed to 
BIV was an increase in the numbers of circulating lympho-
cytes. 
Virus isolation and serological response. Whole blood was 
collected from each calf at least twice during the experimen-
tal period and tested for the presence of infectious BIV and 
antibody to BIV and BVDV. BIV was recovered from all of 
the R29 passage calves at 2 weeks p.i., and BIV-specific 
antibody was detectable in all p.i. sera from calves inocu-
lated with BIV R29 (Table 1; Fig. 3). The strongest serolog-
ical response to BIV was observed in the p2 and p5 calves 
(Fig. 3). No consistent, progressive increases in antibody 
titer or protein specificity were identified in the BIV R29 
passage calves which could be correlated with successive 
passage of BIV. These results suggested that in vivo passage 
of BIV R29 did not dramatically alter levels of virus repli-
cation in vivo. 
In contrast to the BIV R29 passage calves, BIV was not 
recovered from BIV 106-inoculated calves (Table 1). Virus 
could not be reisolated from the pl calf during the prolonged 
febrile period at days 7 through 14 p.i. Therefore, it could not 
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BIV R29 Passage 
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Days Post Inoculation 
FIG. 1. Numbers of circulating lymphocytes (D) and neutrophils (e) in peripheral blood collected from BIV R29 passage calves and BIV 
106 passage calves during the first 6 weeks p.i. The shaded area within the dashed lines includes 95% of the lymphocyte values of age-matched 
control animals (4,200 to 9,560 cells per j.Ll). The shaded area within the solid lines includes 95% of the neutrophil values (1,780 to 6,760 cells 
per 1J.l) of age-matched controls. Arrowheads indicate days when body temperature exceeded 39.7•c. 
be demonstrated that BIV was present in the whole blood 
inoculum transfused into the p2 calf. In addition, BIV-
specific antibody was detectable only in the BIV 106 p1 calf, 
while the p2 and p3 calves remained seronegative throughout 
the experimental period (Fig. 3). The lack of BIV-specific 
antibody in the p2 and p3 calves, and the failure to recover 
virus from the p1 calf early after experimental infection, 
suggested that the BIV 106 inoculum replicated poorly in 
vivo. Importantly, these results indicated that the fever and 
neutropenia observed in the BIV 106 p2 and p3 calves were 
not likely due to BIV replication. In the third experiment, we 
were able to isolate BIV from PBMC collected at 2 and 6 
weeks p.i. from all FBL-BIV R29 calves but from none of 
the FBL controls. The serological response ofFBL-BIV R29 
calves was, in general, stronger than that observed in BIV 
R29 passage calves, especially to the viral envelope glyco-
protein, gpllO (41, 42). 
Results of BVDV serology indicated that none of the 
calves in these experiments were infected with BVDV prior 
to BIV inoculation (data not shown). However, the BIV R29 
p1 through p3 calves and all of the BIV 106 passage calves 
seroconverted to BVDV within 6 weeks p.i. (Table 1). A 
rapid secondary antibody response was detected in all 
BVDV-vaccinated calves inoculated with FBL-BIV R29 
(data not shown). Together, these results confirmed that 
both the BIV R29 stock and the BIV 106 cell-free stock 
contained infectious BVDV. Interestingly, the BIV R29 p4 
and p5 calves did not seroconvert to BVDV by 5 to 6 weeks 
p.i., although both had seroconverted to BIV in a similar 
time frame. This serological evidence indicated that the p4 
and p5 calves were BVDV free and therefore suggested that 
the cycles of neutropenia observed in the p4 calf were a 
consequence of BIV infection. 
Pathological changes in BIV -infected calves. At 5 to 6 weeks 
p.i., BIV R29 passage calves were euthanized and examined 
for gross and histopathological changes. Grossly, lymph 
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Control BIV-infected 
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FIG. 2. Numbers of circulating lymphocytes and neutrophils in peripheral blood during the first 6 weeks following experimental 
inoculation of calves with FBL-BIV R29 or FBL control cells. Shaded areas indicate 95% of lymphocyte or neutrophil values obtained from 
age-matched, noninoculated animals. Individual animals are represented by different symbols within each panel. 
TABLE 1. Detection of virus and antibody in experimentally 
inoculated calves" 
Inoculum Calf Presence BIV BVDV ofBIVb antibody< antibody<' 
BIV R29 p1 + + + 
p2 + + + 
p3 + + + 
p4 + + 
p5 + + 
BIV 106 p1 + + 
p2 ND + 
p3 ND + 
FBL-R29 340 + + +· 
341 + + +· 
342 + + +· 
346 + + +· 
FBL 356 +· 
358 +· 
359 +· 
a Calves experimentally inoculated with either BIV R29, BIV 106, FBL-
BIV R29, or FBL control cells were bled 2 to 3 weeks p.i., and isolated PBMC 
were tested for the presence of BIV by cocultivation with BESP or FBL cells. 
Sera were collected prior to inoculation and at 5 to 6 weeks p.i. and tested for 
antibody to BIV and to BVDV. 
b PBMC (107) were isolated from experimentally inoculated calves at 2 to 3 
weeks p.i. and cocultivated with BESP or FBL cells. The presence of BIV 
was indicated by the appearance of syncytia and, in some cases, by indirect 
immunofluorescence using BIV-specific antibody. All cultures were passaged 
three times before they were considered negative. ND, not determined. 
c BIV seroconversion was determined by Western immunoblot. 
d BVDV seroconversion was detected by indirect immunofluorescence. 
• Calves were vaccinated with killed BVDV vaccine at 2 and 4 weeks prior 
to experimental inoculation. 
nodes often had slight to moderate swelling seen as bulging 
of the parenchyma when the capsule was incised. Infre-
quently, entire lymph nodes or portions of them were 
hyperemic. Hemal nodes were pink to bright red and ranged 
from 2 mm to 1.5 em in diameter. Consistent histologic 
changes characterized as lymphoid follicular hyperplasia 
were found in lymph nodes, hemal nodes, spleen, tonsil, 
Peyer's patches, and other gut-associated lymphoid tissue in 
infected calves. Sections of brain, spinal cord, salivary 
gland, esophagus, trachea, lung, thymus, heart, liver, pan-
creas, adrenal, kidney, abomasum, small intestine, large 
intestine, and bone marrow were normal. 
The most frequent histopathological finding was lymphoid 
hyperplasia, primarily due to expansion of the number and 
size offollicles (Fig. 4). Both primary and secondary follicles 
were present in lymphoid tissues of the control calf; how-
ever, secondary follicles were more numerous in BIV-
infected calves. In the BIV-infected calves, the secondary 
follicles occupied most of the subcapsular cortical space and 
were frequently observed in the deep cortex, especially in 
areas adjacent to fibrous trabeculae. Cells in the center of 
hyperplastic follicles were larger and generally less identifi-
able as histiocytic or lymphocytic types with the exception 
of macrophages containing cytoplasmic tingible bodies. In 
the paracortex, scattered large pale histiocytic cells and 
occasional mitotic figures were present among the predom-
inating large and small lymphocytes. In hemal nodes, mod-
erate to marked follicular hyperplasia was commonly ob-
served and was similar to that observed in the lymph nodes. 
The degree of lymphofollicular hyperplasia was variable 
among the lymph nodes and hemal nodes from different 
anatomic locations and between nodes and other lymphoid 
organs within an infected animal. The degree of hyperplasia 
also varied among the infected animals; however, patholog-
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FIG. 3. Western immunoblot analysis of BIV antibody response in BIV-inoculated and control calves. Lanes: A, sera collected prior to 
inoculation; 8, sera collected 5 to 8 weeks p.i.; c-, a negative control calf inoculated with whole blood from a BIV-seronegative calf; c+, 
positive control serum from a cow experimentally infected with BIV R29. Locations of major BIV proteins (41, 42) are indicated. 
ical changes did not increase in severity with progressive 
passage of BIV, nor could differences be attributed to the 
presence or absence of concurrent BVDV infection. 
In situ hybridization. To determine sites of BIV replication 
in vivo, certain tissues, including spleen, lymph node, liver, 
lung, and PBMC, were analyzed by in situ hybridization. 
BIV-specific RNA probes were prepared as described above 
and initially tested for specificity and sensitivity, using 
cytospin preparations of BIV-infected and non-infected 
MDBK cells. No hybridization signals above background 
were observed with use of the plus-sense probe, indicating 
that the levels of BIV DNA were low in all in vitro and in 
vivo samples tested. With the minus-sense probe, however, 
positive hybridization signals representing BIV mRNA 
and/or virion RNA were detectable. BIV RNA could be 
detected in cell culture material after only 3 days of exposure 
of the autoradiographic emulsion, and after 18 days, heavy 
grain formation was observed (Fig. 5). In contrast, relatively 
few grains were present in PBMC from BIV -infected calves 
after 1 month of exposure. Thus, the levels of BIV RNA in 
virus-infected cells in vivo were at least 10-fold lower than 
RNA levels detected in in vitro cell culture. In addition to 
the relatively low levels of virus expression per cell, the 
number of BIV-infected PBMC was found to be less than 
25/10S cells (Table 2). Analysis of tissue from BIV R29 
passage calves identified only a rare BIV-positive cell in the 
spleen, liver, and lymph node connective tissue (data not 
shown). However, no evidence of BIV replication could be 
detected in lymph node germinal centers. 
DISCUSSION 
BIV was originally isolated from a cow with persistent 
lymphocytosis (38). In the original studies of BIV pathogen-
esis, VanDerMaaten et al. reported that calves inoculated 
with BIV developed a mild lymphocytosis and moderate 
lymphoproliferation in the small subcutaneous lymphatic 
nodules (38). The virus was found to be morphologically 
similar to visna virus (11, 38) and was later demonstrated to 
have antigenic and genetic similarity to HIV (19, 21). The 
structural similarities between BIV and HIV, as well as the 
presence of lymphadenopathy in BIV -infected calves, indi-
cated that BIV may provide a useful animal model of the 
pathogenesis of HIV infection (21). In the present study, 
experimental infection of calves with BIV was found to 
induce mild lymphoproliferative changes within the first 6 
weeks following infection. These changes included follicular 
hyperplasia in lymph nodes, hemal nodes, and spleen as well 
as increased numbers of lymphocytes in peripheral blood. 
Histopathological changes in BIV-infected calves con-
sisted of follicular hyperplasia in lymphoid tissues. The 
extent of hyperplasia was variable among the infected ani-
mals; however, all had secondary follicles in which prolifer-
ation offollicle center cells had progressed to impinge on the 
mantle zone of small lymphocytes. These changes are simi-
lar to early-stage lymph node alterations in patients with 
HIV-1 infections (16, 20, 30). Thus, follicular hyperplasia 
without follicular fragmentation characterizes both the early 
response to BIV infection in calves as well as the early 
response to HIV-1 infections in humans. Similar lymphoid 
changes have also been described for SIV (17) and FIV (44). 
In both HIV and SIV infections, follicular hyperplasia is due 
in part to the formation of antigen-antibody complexes and 
antigen trapping within the lymphoid follicle (31, 43). Anti-
gen-antibody complexes may also be involved in BIV-
induced follicular hyperplasia, as all animals had serocon-
verted to BIV prior to postmortem examination. In addition, 
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a 
FIG. 4. Pathological changes in lymph nodes and hemal nodes following experimental inoculation of BIV R29. (a) Subcapsular primary 
follicle in the lymph node of a control calf. Note the Jack of a mantle zone of small lymphocytes surrounding the follicle center (arrowhead). 
H&E stain, x SO. (b) Higher magnification of control lymph node showing unstimulated follicle center cells and moderate numbers of small 
lymphocytes and larger histiocytic cells with abundant pale cytoplasm and vesicular nuclei . H&E stain, x 160. (c) Lymph node from the BIV 
R29 p5 calf taken at 6 weeks p.i. Note the increased number of secondary follicles in both the subcapsular and deep cortex (arrowheads). H&E 
stain, xso. (d) Lymph node secondary follicle from the BIV R29 p5 calf showing proliferation of follicle center cells, scattered histiocytes with 
stainable granular debris in the cytoplasm, shrunken cells with pyknotic or fragmented nuclei (apoptotic cells), and a mantle of small 
lymphocytes. H&E stain, x 160. (e) Hemal node from the BIV R29 p1 calf at 6 weeks p.i . showing follicular hyperplasia. One secondary 
follicle and portions of two others are indicated by arrowheads. H&E stain, xSO. (0 Higher magnification of panel e showing follicular changes 
similar to those in panel d. H&E stain, x 160. 
we were unable to detect BIV -infected cells in germinal 
centers of hyperplastic follicles by in situ hybridization, 
suggesting that hyperplasia was not a direct result of virus 
replication within the germinal center. These findings are 
similar to those reported for in vivo infection with SIV, 
where few virus-infected cells are detectable in lymph node 
germinal centers during stages of follicular hyperplasia (43) . 
Interestingly, the number of SIV -infected cells increases 
during later stages of follicular depletion (43). At present, it 
is not known whether degenerative changes in lymphoid 
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FIG. 5. In situ hybridization for detection of BIV-infected cells. 
Cells (1ij5) were cytocentrifuged onto poly-o-Iysine-coated slides 
and hybridized with a minus-sense BIV L TR probe as described in 
Materials and Methods. (a) PBMC taken 6 weeks p.i. from a calf 
inoculated with FBL control cells. After 1 month of exposure, only 
background grains are seen. (b) PBMC taken 6 wee~s J>".i. from a calf 
inoculated with FBL-BIV R29. After 1 month of exposure, a 
significant number of grains representing hybridization to BIV RNA 
are seen over the nucleus and cytoplasm of an infected cell. (c) 
MDBK cells exposed for 18 days . Only background numbers of 
grains are observed. (d) MDBK cells chronically infected with BIV 
R29. After 18 days of exposure, very high numbers of grains are 
seen over an infected cell. -
EARLY PATHOGENESIS OF BIV 1081 
TABLE 2. Quantitation of BIV-infected PBMC by 
in situ hybridization• 
Inoculum Calf Positive cells/lOS PBMCb 
FBL-BIV R29 340 6 
341 5 
342 5 
346 22 
FBL 356 0 
358 0 
359 0 
• PBMC were isolated from whole blood at 6 weeks p.i. from calves 
experimentally inoculated with FBL-BIV R29 or with FBL control cells; lOS 
cells were cytocentrifuged onto poly-o-lysine-coated slides and hybridized 
with a minus-sense BIV LTR probe as described in Materials and Methods. 
b Cells were scored as positive when the number of grains over an 
individual cell was at least fivefold higher than the number of grains over 
uninfected cells. 
follicles associated with viral replication within the germinal 
center are characteristic features of a later stage of BIV 
infection in vivo. 
In addition to the mild lymphoproliferative changes, tran-
sient periods of fever and neutropenia were observed in 
experimentally infected calves. These findings are similar to 
those reported for experimental infection of cats with FlY 
(44) and in acute stages of HIV infection (18). However, 
acute BVDV infection of cattle is characterized by biphasic 
febrile episodes and neutropenia during the first 2 weeks 
following infection (23, 32, 36). Because BVDV was present 
in almost all of the BIV-inoculated calves, it was not always 
possible to determine whether clinical changes were due to 
BVDV, BIV, or both. 
The R29 stock of BIV has been shown to contain mixtures 
of viral genotypes; however, the predominant virus geno-
type appears to be BIV 106-like (12). Thus, it is interesting to 
note that although R29 could be readily transmitted at 2 
weeks p.i., we were unable to transmit the molecular clone 
BIV 106. These results may indicate that the BIV 106 
molecular clone replicates poorly in vivo and that other 
genotypes better suited to in vivo replication may be present 
in the BIV R29 stock. However, the differences in in vivo 
replication may be more characteristic of the particular 
inoculum used in these experiments. The R29 p1 calf was 
inoculated with virus-infected cells and culture supernatant, 
while the BIV 106 p1 calf was inoculated with cell-free virus. 
Studies in our laboratory indicate that in vitro transmission 
of BIV occurs more readily if the inocula contain infected 
cells rather than cell-free virus. Ongoing studies to charac-
terize isolates recovered during in vivo passage should 
provide a better understanding of the biological and genetic 
phenotypes present in the R29 stock of BIV. 
In this study, the extent of the clinical and pathological 
changes following experimental BIV infection was less pro-
nounced than was described for naturally infected cattle 
(38). These results are consistent with previous studies of 
experimental BIV infections (38, 39) in which the magnitude 
of lymphocytosis was considerably less than that observed 
in the naturally infected cattle from which BIV was orig-
inally isolated (38). A variety offactors may contribute to the 
observed differences between naturally infected and exper-
imentally infected animals. One factor is the time required 
for the clinical manifestations of disease to appear. The 
original BIV -infected cow, R29, was 8 years of age at the 
time of BIV isolation, and in subsequent experimental infec-
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tions, palpable hemal nodes were not detected until3 months 
postinfection (38). A second factor is the possibility that BIV 
virulence depends on the presence of additional cofactors 
present in the naturally infected animal. BL V is endemic in 
many parts of the southern United States, and coinfection of 
cattle with BIV and BL V could result in enhanced lym-
phoproliferation. BL V had not been identified as the caus-
ative agent of bovine lymphosarcoma at the time of the 
original isolation of BIV, and it is not known whether cattle 
from which BIV was isolated were in fact coinfected with 
BL V. A third factor to consider is that the current stocks of 
BIV may have lost virulence as a result of long-term in vitro 
culture. We have shown that in vitro culture can rapidly 
select for lentivirus isolates with altered biological pheno-
types, including decreased virulence (14). In this study, we 
attempted to increase viral virulence by rapid in vivo pas-
sage. Although similar strategies have proved successful 
with other lentiviruses (29), we observed no increase in 
levels of virus replication, serological response, or clinical 
and pathological changes which specifically correlated with 
successive in vivo passage. Therefore, it is not clear whether 
low virulence is a biological phenotype of the R29 stock or, 
rather, is representative of all isolates of BIV. Identification 
and characterization of additional field isolates of BIV are 
needed to increase our knowledge of BIV pathogenesis. 
In summary, the results of this study indicate that the 
pathological changes during the early periods following 
experimental infection of calves with BIV are characteristic 
of several immunosuppressive lentiviruses, including HIV, 
SIV, and FIV. Together with the genetic and antigenic 
relatedness of these viruses, the in vivo studies suggest that 
BIV is a useful animal model for the study of the early events 
in HIV pathogenesis. Ongoing studies to define the long-
term pathogenic effects of BIV infection in vivo will deter-
mine the appropriateness of BIV as an animal model of 
HIV-associated immune deficiency syndrome. 
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